The UNMC College of Medicine recently received grants and awards representing more than $5.7 million in new funding. Awards included:
- Kelly Stauch, PhD, neurological sciences, received a grant of $2 million from the U.S. Army/USAMRAA/CDMRP to study interrelationship between PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson’s disease.
- Howard Fox, MD, PhD, neurological sciences, received a grant of $79,496 from the San Diego Biomedical Research Institute to study methamphetamine, HIV integration and latency in the brain.
- Navya Basrur, PhD, obstetrics and gynecology, received a grant of $55,000 from the Lalor Foundation for a study elucidating the role of CREB in response to follicle stimulating hormone in granulosa cells.
- Brad Becken, MD, pediatrics-infectious diseases, received a grant of $50,000 from NSF for “I-Corps: Translation Potential of an Automated Dynamic Antibiogram.”
- Josue Avecillas-Chasin, MD, PhD, neurosurgery, received a grant of $50,000 from the Neurosurgery Research and Education Foundation as the SSFN Award for thalamic seizure network mapping in patients with medication-refractory epilepsy treated with responsive neurostimulation targeting the thalamus.
- David Mercer, MD, PhD, surgery-transplant, received a grant of $43,387 from the University of Pittsburgh for a study defining pediatric intestinal failure natural history.
- Omar Abughanimeh, MBBS, internal medicine-oncology/hematology, received a grant of $37,454 from the Alliance Foundation Trials for a trial of neoadjuvant and adjuvant atezolizumab with or without Tiragolumab in conjunction with chemoradiotherapy for unresectable stage III NSCLC.
- Sidharth Mahapatra, MD, PhD, pediatrics-critical care, received a grant of $5,600 from the University of Pennsylvania for the “ENdotypes in Children with Severe Acute Respiratory Distress SyNdrome: ImpAct on REsponse to Treatment (ENSNARE)” study.
Industry-sponsored grants and contracts:
The following industry-sponsored grants and contracts were received.
- Shubham Agarwal, MBBS, internal medicine-DEM, received funding to trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants.
- Howard Gendelman, MD, pharmacology and experimental neuroscience, received funding to investigate the safety, tolerability, pharmacokinetics and efficacy of Lu AF28996 in patients with Parkinson’s disease.
- Julie Vose, MD, internal medicine-oncology/hematology, received funding for a study of MB-105 in patients with CD5 positive (CD5+) relapsed / refractory T cell lymphoma (r/r TCL).
- David Berkheim, MD, surgery-cardiothoracic surgery, received funding for a study to evaluate Cemiplimab plus chemotherapy versus Cemiplimab plus chemotherapy plus other cancer treatments for the perioperative treatment of patients with resectable non-small cell lung cancer.
- Anupam Kotwal, MD, internal medicine-DEM, received funding for a study to assess the efficacy, safety, and tolerability of imvt-1402 as treatment for adult patients with graves’ disease.
- Christopher D’Angelo, MD, internal medicine-oncology/hematology, received funding for a study to investigate the efficacy and safety of Sonrotoclax combined with Zanubrutinib compared with Zanubrutinib monotherapy in adult patients with previously untreated chronic lymphocytic leukemia.
- Adam Burdoff, DO, internal medicine-cardiovascular, received funding for a trial to evaluate safety and effectiveness of mechanical circulatory support in patients with advanced heart failure.
- Brad Brabec, MD, pediatrics-health system sciences, received funding for a study to assess the long-term safety and tolerability of Rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents 6 to younger than 18 years of age.
- Kelsey Klute, MD, internal medicine-oncology/hematology, received funding for validation of early detection biomarkers in a heritable high-risk cohort in the PRECEDE Ancillary Study.